Literature DB >> 25017148

Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.

Jagat R Kanwar1, Ganesh Mahidhara, Kislay Roy, Sreenivasan Sasidharan, Subramanian Krishnakumar, Neerati Prasad, Rakesh Sehgal, Rupinder K Kanwar.   

Abstract

AIM: To validate the anticancer efficacy of alginate-enclosed, chitosan-conjugated, calcium phosphate, iron-saturated bovine lactoferrin (Fe-bLf) nanocarriers/nanocapsules (NCs) with improved sustained release and ability to induce apoptosis by downregulating survivin, as well as cancer stem cells. MATERIALS &
METHODS: The stability, nanotoxicity of the modified nanoformulation was evaluated and their anticancer efficacy was re-examined. Their mechanism of internalization was studied and we identified the role of various miRNAs in absorption of these NCs/iron in various body parts of mice. We determined the effect of these NCs on survivin, stem cell markers, red blood cell count, iron, calcium and zinc concentration in mice, determined the antiangiogenic properties of these NCs and studied their effect on cancer stem-like cells.
RESULTS: Spherical NCs (396.1 ± 27.2 nm) exceedingly reduced viability of Caco-2 cells (32 ± 2.83%). The NCs also showed effective internalization and reduction of cancer stem cell markers in triple-positive CD133, survivin and CD44 cancer stem-like cells. Mice treated with the NCs showed no nanotoxicity and did not develop any tumors in xenograft colon cancer models. We found that the serum iron, zinc and calcium absorption were increased. DMT1, LRP, transferrin and lactoferrin receptors were responsible for internalization of the NCs. Different miRNAs were responsible for iron regulation in different organs. Interestingly, NCs inhibited survivin and its different isoforms.
CONCLUSION: Our results confirmed that NCs internalized and changed the expression of selected miRNAs that further enhanced their uptake. The NCs activated both extrinsic, as well as intrinsic apoptotic pathways to induce apoptosis by targeting survivin in cancer cells and cancer stem cells, without inducing any nonspecific nanotoxicity. Apart from inhibiting angiogenesis and stem cell markers, NCs also maintained iron and calcium levels.

Entities:  

Keywords:  Fe-bLf; absorption; iron metabolism; miRNA; nanocarriers/nanocapsules; nanotoxicity; oral delivery; stem cell; survivin; xenograft

Mesh:

Substances:

Year:  2014        PMID: 25017148     DOI: 10.2217/nnm.14.132

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  27 in total

Review 1.  Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors:  Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Cissus quadrangularis inhibits IL-1β induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling.

Authors:  Jagat R Kanwar; Rasika M Samarasinghe; Kuldeep Kumar; Ramesh Arya; Sanjeev Sharma; Shu-Feng Zhou; Sreenivasan Sasidharan; Rupinder K Kanwar
Journal:  Drug Des Devel Ther       Date:  2015-06-05       Impact factor: 4.162

3.  Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer.

Authors:  Jessica A Gibbons; Jagat R Kanwar; Rupinder K Kanwar
Journal:  BMC Cancer       Date:  2015-05-22       Impact factor: 4.430

4.  Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism.

Authors:  Ganesh Mahidhara; Rupinder K Kanwar; Kislay Roy; Jagat R Kanwar
Journal:  Int J Nanomedicine       Date:  2015-06-22

Review 5.  Molecular targets in arthritis and recent trends in nanotherapy.

Authors:  Kislay Roy; Rupinder Kaur Kanwar; Jagat Rakesh Kanwar
Journal:  Int J Nanomedicine       Date:  2015-08-26

6.  Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite-host interaction.

Authors:  Namrata Anand; Rupinder K Kanwar; Mohan Lal Dubey; R K Vahishta; Rakesh Sehgal; Anita K Verma; Jagat R Kanwar
Journal:  Drug Des Devel Ther       Date:  2015-07-27       Impact factor: 4.162

7.  Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii.

Authors:  Namrata Anand; Rakesh Sehgal; Rupinder Kaur Kanwar; Mohan Lal Dubey; Rakesh Kumar Vasishta; Jagat Rakesh Kanwar
Journal:  Int J Nanomedicine       Date:  2015-10-08

8.  Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.

Authors:  Kislay Roy; Yogesh S Patel; Rupinder K Kanwar; Rangam Rajkhowa; Xungai Wang; Jagat R Kanwar
Journal:  Int J Nanomedicine       Date:  2015-12-21

9.  Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf).

Authors:  Fawzi Ebrahim; Jayanth Suryanarayanan Shankaranarayanan; Jagat R Kanwar; Sneha Gurudevan; Uma Maheswari Krishnan; Rupinder K Kanwar
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

10.  Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.

Authors:  Sishir K Kamalapuram; Rupinder K Kanwar; Kislay Roy; Rajneesh Chaudhary; Rakesh Sehgal; Jagat R Kanwar
Journal:  Int J Nanomedicine       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.